Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.

Current Opinion in Neurology
Yong Wook JungIn-Hyun Park

Abstract

The lack of effective treatments for various neurodegenerative disorders has placed huge burdens on society. We review the current status in applying induced pluripotent stem cell (iPSC) technology for the cellular therapy, drug screening, and in-vitro modeling of neurodegenerative diseases. iPSCs are generated from somatic cells by overexpressing four reprogramming factors (Oct4, Sox2, Klf4, and Myc). Like human embryonic stem cells, iPSCs have features of self-renewal and pluripotency, and allow in-vitro disease modeling, drug screening, and cell replacement therapy. Disease-specific iPSCs were derived from patients of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and spinal muscular atrophy. Neurons differentiated from these iPSCs recapitulated the in-vivo phenotypes, providing platforms for drug screening. In the case of Parkinson's disease, iPSC-derived dopaminergic neurons gave positive therapeutic effect on a rodent Parkinson's disease model as a proof of principle in using iPSCs as sources of cell replacement therapy. Beyond iPSC technology, much effort is being made to generate neurons directly from dermal fibroblasts with neuron-specific transcri...Continue Reading

References

Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·S KellyG K Steinberg
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anselme L PerrierLorenz Studer
Feb 3, 2005·Nature Biotechnology·Xue-Jun LiSu-Chun Zhang
Jun 3, 2005·The Journal of Clinical Investigation·Lars Bertram, Rudolph E Tanzi
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Feb 19, 2008·Nature Biotechnology·Kenji OsafuneDouglas A Melton
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marius WernigRudolf Jaenisch
Aug 12, 2008·Cell·In-Hyun ParkGeorge Q Daley
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rutger-Jan SwijnenburgJoseph C Wu
Sep 5, 2008·The Journal of Clinical Investigation·Stefania CortiGiacomo P Comi
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Jan 27, 2009·Development·Konrad Hochedlinger, Kathrin Plath
Apr 21, 2009·Methods in Molecular Biology·Wendy PhillipsRoger A Barker
Jul 11, 2009·Nature Biotechnology·Kyoko MiuraShinya Yamanaka
Sep 19, 2009·Trends in Pharmacological Sciences·Stefan R BraamChristine L Mummery
Oct 16, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne B Young
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bao-Yang HuSu-Chun Zhang
Apr 16, 2010·Human Molecular Genetics·Christian L LorsonMonir Shababi
Jul 28, 2010·Biochemical Society Transactions·Delphine LaustriatMarc Peschanski
Aug 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Gunnar HargusOle Isacson
Feb 5, 2011·Nature Biotechnology·Gabriella L BoultingKevin Eggan
May 5, 2011·Nature Cell Biology·Sean M Wu, Konrad Hochedlinger
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ulrich PfistererMalin Parmar
Aug 20, 2011·Cell Stem Cell·Esther Y SonKevin Eggan
Sep 9, 2011·Human Molecular Genetics·Takuya YagiNorihiro Suzuki
Sep 10, 2011·Annals of Neurology·J Simon LunnEva L Feldman

❮ Previous
Next ❯

Citations

Jun 15, 2012·Journal of Neural Transmission·Lezanne OoiGerald Münch
Nov 9, 2012·Molecules and Cells·Yoshiaki TanakaIn-Hyun Park
Dec 12, 2012·TheScientificWorldJournal·Yang YangLimin Rong
Oct 17, 2013·Human Molecular Genetics·Yoshiaki TanakaIn-Hyun Park
May 16, 2014·Human Molecular Genetics·Christopher A Ross, Sergey S Akimov
Jul 31, 2014·Stem Cells and Development·Huen Suk KimIhor R Lemischka
Jul 3, 2013·Pharmacological Reviews·George J ChristKarl-Erik Andersson
Jul 4, 2012·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Richard L Carter, Anthony W S Chan
Mar 31, 2015·Journal of Cell Communication and Signaling·Payam Ghasemi-DehkordiMorteza Hashemzadeh-Chaleshtori
Jun 24, 2016·Expert Opinion on Therapeutic Patents·Aleksandra MarchwickaGeoffrey Brown
Mar 8, 2017·Cellular Reprogramming·Farzaneh RamiRasoul Salehi
Nov 6, 2018·Stem Cells Translational Medicine·Yingchao XueMingyao Ying
Sep 21, 2018·Frontiers in Neuroscience·Alastair I GraingerEric J Hill
Jul 7, 2018·BioImpacts : BI·Fahsai KantawongThasaneeya Kuboki
Jan 15, 2019·Molecular Therapy. Nucleic Acids·Subbroto Kumar SahaKi-Hyun Kim
Jun 17, 2019·Life Sciences·Forough Chakari-KhiaviMehdi Yousefi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.